Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch

Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: The case of lysostaphin

Igor Mierau1 email, Peter Leij1 email, Iris van Swam1 email, Barry Blommestein1 email, Esther Floris1 email, James Mond2 email and Eddy J Smid1 email

NIZO food research, P.O. Box 20, 6710 BA Ede, The Netherlands

Biosynexus, Inc., 9119 Gaither Road, Gaithersburg, MD 20877, USA

author email corresponding author email

Microbial Cell Factories 2005, 4:15doi:10.1186/1475-2859-4-15

Published: 27 May 2005

Abstract

Background

The NIsin-Controlled gene Expression system NICE of Lactococcus lactis is one of the most widespread used expression systems of Gram-positive bacteria. It is used in more than 100 laboratories for laboratory-scale gene expression experiments. However, L. lactis is also a micro-organism with a large biotechnological potential. Therefore, the aim of this study was to test whether protein production in L. lactis using the NICE system can also effectively be performed at the industrial-scale of fermentation.

Results

Lysostaphin, an antibacterial protein (mainly against Staphylococcus aureus) from S. simulans biovar. Staphylolyticus, was used as a model system. Food-grade lysostaphin expression constructs in L. lactis were grown at 1L-, 300-L and 3000-L scale and induced with nisin for lysostaphin production. The induction process was equally effective at all scales and yields of about 100 mg/L were obtained. Up-scaling was easy and required no specific effort. Furthermore, we describe a simple and effective way of downstream processing to obtain a highly purified lysostaphin, which has been used for clinical phase I trials.

Conclusion

This is the first example that shows that nisin-regulated gene expression in L. lactis can be used at industrial scale to produce large amounts of a target protein, such as lysostaphin. Downstream processing was simple and in a few steps produced a highly purified and active enzyme.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.